CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1
暂无分享,去创建一个
L. Meyer | M. Sinet | A. Urrutia | C. Goujard | A. Venet | M. Chaix | C. Lacabaratz-Porret | Jean-Marc Doisne
[1] R. Welsh,et al. Plasticity of T Cell Memory Responses to Viruses , 2004, Immunity.
[2] R. V. van Lier,et al. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. , 2003, Blood.
[3] J. Baatz,et al. Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals , 2003, Journal of Translational Medicine.
[4] J. Corbeil,et al. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. , 2003, The Journal of infectious diseases.
[5] M. Gougeon,et al. Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.
[6] Matthew Jones,et al. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation. , 2003, AIDS research and human retroviruses.
[7] R. Morisset,et al. Studies on the Production of IL-15 in HIV-Infected/AIDS Patients , 2003, Journal of Clinical Immunology.
[8] R. Koup,et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. , 2003, Immunity.
[9] Marc Dalod,et al. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. , 2003, The Journal of infectious diseases.
[10] J. Altman,et al. IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.
[11] Stefan Kostense,et al. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. , 2002, Trends in immunology.
[12] S. Kostense,et al. Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection , 2002, AIDS.
[13] R. Welsh,et al. Dynamics of Memory T Cell Proliferation Under Conditions of Heterologous Immunity and Bystander Stimulation1 , 2002, The Journal of Immunology.
[14] D. Richman,et al. Dynamics of T Cell Responses in HIV Infection , 2002, The Journal of Immunology.
[15] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[16] G. d’Ettorre,et al. Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients , 2002, AIDS.
[17] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[18] J. Bennink,et al. Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells , 2001, Journal of Virology.
[19] L Meyer,et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. , 2001, Blood.
[20] W. Rozenbaum,et al. Quantification of Epstein‐Barr virus load in peripheral blood of human immunodeficiency virus‐infected patients using real‐time PCR , 2001, Journal of medical virology.
[21] B. Gazzard,et al. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. , 2001, Blood.
[22] P. Burkett,et al. T Cell–Independent Interleukin 15rα Signals Are Required for Bystander Proliferation , 2001, The Journal of experimental medicine.
[23] F. Gheyas,et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.
[24] Raymond M. Welsh,et al. Attrition of Bystander CD8 T Cells during Virus-Induced T-Cell and Interferon Responses , 2001, Journal of Virology.
[25] J. Sprent,et al. An IFN-γ-Dependent Pathway Controls Stimulation of Memory Phenotype CD8+ T Cell Turnover In Vivo by IL-12, IL-18, and IFN-γ1 , 2001, The Journal of Immunology.
[26] P. Doherty,et al. Virus-Specific and Bystander CD8+T-Cell Proliferation in the Acute and Persistent Phases of a Gammaherpesvirus Infection , 2001, Journal of Virology.
[27] G. Stewart,et al. In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12). , 2001, AIDS research and human retroviruses.
[28] E. Rosenberg,et al. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.
[29] H. Macdonald,et al. Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation , 2000, The Journal of Immunology.
[30] S. Rowland-Jones,et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection , 2000, AIDS.
[31] D. Pardoll,et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. , 1999, Immunity.
[32] C. Rouzioux,et al. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. , 1999, The Journal of clinical investigation.
[33] H. Naora,et al. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression , 1999, Cell Death and Differentiation.
[34] J. Guillet,et al. Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+ Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy , 1999, Journal of Virology.
[35] G. Trinchieri,et al. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. , 1999, Blood.
[36] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[37] J V Giorgi,et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.
[38] Kaufmann,et al. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV‐1 infection correlates with markers of disease severity and changes towards normalization under treatment , 1999, Clinical and experimental immunology.
[39] S. Rowland-Jones,et al. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. , 1999, Journal of immunology.
[40] A. Rothman,et al. Analysis of Murine CD8+ T-Cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-Reactivity and Influence of Infecting Serotype , 1999, Journal of Virology.
[41] S. Varga,et al. Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.
[42] D. Mason,et al. A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.
[43] J. Sprent,et al. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.
[44] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[45] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.
[46] I. Frank,et al. IL-15 enhances immune functions during HIV infection. , 1997, Journal of immunology.
[47] R. Welsh,et al. Minimal Bystander Activation of CD8 T Cells during the Virus-induced Polyclonal T Cell Response , 1997, The Journal of experimental medicine.
[48] R. Zinkernagel,et al. Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model , 1997, The Journal of experimental medicine.
[49] M. Dierich,et al. Role of IL‐15 in HIV‐1‐associated hypergammaglobulinaemia , 1997, Clinical and experimental immunology.
[50] X. Jin,et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.
[51] N. Letvin,et al. IL-15 stimulates the expansion of AIDS virus-specific CTL. , 1996, Journal of immunology.
[52] M. Lederman,et al. Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. , 1996, The Journal of clinical investigation.
[53] J. Bell,et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis , 1996, Nature Medicine.
[54] J. Sprent,et al. Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.
[55] Persephone Borrow,et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV , 1994, Nature.
[56] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[57] G. Trinchieri,et al. Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.
[58] R. Zinkernagel,et al. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. , 1992, Journal of immunology.
[59] A. Fauci,et al. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.
[60] M. Sinet,et al. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. , 1996, AIDS research and human retroviruses.